Sentences with phrase «pharma company ceos»
President Donald Trump sat down with a host of major pharma company CEOs Tuesday morning to address pressing issues like high drug prices, the future of the FDA, and where treatments are produced.
http://fortune.com/ Not exact matches
On average, the 30 large and small pharmaceutical and biotech companies IDEA Pharma examined got just 11 % of their 2017 revenue from drugs developed within the past five years, says Mike Rea, the firm's CEO and one of the most insightful people I've met — no exaggeration — when it comes to pinpointing innovation choke points in the drug industry.
-- Ahmed Albaiti, founder and CEO of Medullan, a digital health innovation company that works with payers, providers, and pharma on patient engagement.
At that price, he would collect $ 800 million, or $ 200 million a year over four years — making more than the CEOs of more than a dozen major pharma companies are likely to be paid, combined.
But it appears that CEO and founder Jean - Paul Clozel just isn't too keen on selling the company he's built, leading the U.S. pharma giant to walk away from the negotiating table and its $ 20 billion offer.
Valeant CEO Mike Pearson said in a conference call that Medicis will strengthen the company's place in medical dermatology and bring it to critical mass in aesthetics, a $ 12 - billion market that doesn't depend on government health - plan reimbursement and previously did not have a significant «big pharma» presence.
That deal cemented Actavis's rebirth as a branded and specialty pharma company — or as CEO Brent Saunders said, a pioneer «in a new industry model: Growth Pharma.&pharma company — or as CEO Brent Saunders said, a pioneer «in a new industry model: Growth Pharma.&Pharma.»
US: Heather Bresch, the CEO of Mylan, an American pharmaceuticals company, finds herself at the center of one of the biggest pharma controversies in recent years: price - gouging.
From 1997 - 2008, Joern was President and CEO of Evotec AG, where he designed many alliances with leading pharma and biotech companies, listed the Company on the Frankfurt Stock Exchange and NASDAQ, and managed the acquisition of LSE - listed Oxford Asymmetry and NASDAQ - listed Renovis Inc..